APLIF - Appili Therapeutics beats on revenue February, 12 2021 05:07 PM Appili Therapeutics Inc Appili Therapeutics (APLIF): 9M GAAP EPS of -$0.16.As of Dec. 31, 2020, the Company had cash and short-term investments of $20.29M.Press Release For further details see: Appili Therapeutics beats on revenue